Perfect Holding Reveals Unaudited FY2023 Financial Statements of Kinarus Therapeutics

• Unaudited financial statements for FY2023 published by Kinarus Therapeutics Holding AG - Decision should be based on audited financial statements, not unaudited ones - Kinarus Holding is a therapeutic drug development company listed on the SIX Swiss Exchange - Business Combination with Curatis AG proposed, with closing expected by end of April 2024 - Kinarus AG in Liquidation filed for bankruptcy in September 2023 after financing agreement with Chinese investment company failed - Investor Relations contact: Thomas Bieri, Managing Partner of YUMA Capital. Contact information: Tel: [phone], email: [e-mail]